Health Agencies Update |

Rotavirus Vaccine

Bridget M. Kuehn
JAMA. 2010;304(24):2687. doi:10.1001/jama.2010.1816.
Text Size: A A A
Published online


The US Centers for Disease Control and Prevention (CDC) continues to recommend vaccination of infants with 2 rotavirus vaccines, Rotarix and RotaTeq, despite emerging reports from large clinical trials in other countries of a small risk of intussusception.

In September, the US Food and Drug Administration announced a change in the label for Rotarix to indicate an increased risk of intussusception among infants during the month after the first dose (http://tinyurl.com/25589oc). The information was based on preliminary data from a postmarketing trial of the vaccine in Mexico, which found an 1.8-fold increased risk of intussusception. On October 28, the CDC's Advisory Committee on Immunization Practices (ACIP) evaluated data from this trial and other postmarketing studies in Latin America and Australia that have suggested an increased risk of intussusception shortly after vaccination with Rotarix or RotaTeq. So far, a study of more than 800 000 doses of RotaTeq in the United States through the Vaccine Safety Datalink (a collaborative effort between the CDC and 8 managed care organizations) has not found an increased risk. The ACIP noted in a statement that if an increased risk of intussusception exists in the United States similar to that seen in the Mexican study, about 1 case of intussusception would occur per 100 000 US infants receiving the vaccine.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles